Status:

UNKNOWN

(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia

Lead Sponsor:

Assiut University

Conditions:

Benign Prostatic Hyperplasia

Eligibility:

MALE

45-75 years

Phase:

NA

Brief Summary

To compare between efficacy of phosphodiesterase5 inhibitors (tadalafil 5 mg) and Alpha Blockers (tamsulosin 0.4 mg) monotherapy vs combined therapy in treatment of lower urinary tract symptoms of ben...

Detailed Description

The proposed research aims to answer the question about efficacy and safety of phosphodiesterase 5 inhibitors (tadalafil 5 mg) and Alpha Blockers (tamsulosin 0.4 mg) monotherapy vs combined therapy in...

Eligibility Criteria

Inclusion

  • 1 - Men \> 45 years with LUTS/BPH for \> 6 months 2- IPSS of ≥ 8 and Qmax of ≥ 4 to≤ 15 mL/s

Exclusion

  • PSA level of \> 10.0 ng/mL (if ≥ 4.0 to≤ 10.0 ng/mL prostate cancer will be excluded).
  • Post-voidresidual urine volume of ≥ 150 mL.
  • Previous Urine Retention or Urethral Catheterization .
  • other pathology such as urinary bladder stone , bladder mass or neurogenic bladder .
  • Any case of LUTS other than BPH (urinary bladder stone, neurogenic bladder, bladder neck contracture,rethral stricture, bladder cancer, acute or chronic prostatitis, acute or chronic urinary tract infection).
  • patients supposed to undergo intraocular operation (as cataract operation) .
  • History of head injury or cerebrovascular stroke or spinal injury.
  • pelvic fracture.
  • Uncontrolled diabetic patient.
  • Patients with chronic obstructive lung disease on medical treatment.
  • Parasympatholytic drugs are contraindicated during the study. 12. Patients refusing to share in the study.

Key Trial Info

Start Date :

May 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2024

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT05236634

Start Date

May 1 2022

End Date

June 30 2024

Last Update

February 11 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia | DecenTrialz